Causal Relationship Between Plasma VEGF Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study

NCT06620068 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 207473

Last updated 2024-10-01

No results posted yet for this study

Summary

This study aims to investigate the causal relationship between plasma vascular endothelial growth factor (VEGF) family proteins and placenta previa using a two-sample Mendelian randomization (MR) approach. Genome-wide association study (GWAS) data will be analyzed to assess the correlation and potential causality between VEGF protein levels and the occurrence of placenta previa.

Conditions

  • Placenta Previa

Sponsors & Collaborators

  • The Second People's Hospital of Foshan

    collaborator OTHER
  • First People's Hospital of Foshan

    collaborator OTHER
  • Maternal and Child Health Hospital of Foshan

    collaborator OTHER
  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-25
Primary Completion
2024-11-01
Completion
2024-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06620068 on ClinicalTrials.gov